1620 Investment Advisors »

Tarsus Pharmaceuticals shares owned by 1620 Investment Advisors

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by 1620 Investment Advisors from 13F filings

Historical chart of 1620 Investment Advisors investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by 1620 Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by 1620 Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $108k 1.8k 59.43
2025-06-30 $74k 1.8k 40.51

More positions owned by 1620 Investment Advisors

Spdr Portfolio Intermediate Term Corporate Bond Etf Etf (SPIB)
Spdr Msci Eafe Strategicfactors Etf Etf (QEFA)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
JPMorgan Chase & Co. (JPM)
Tri Contl Corp Cef (TY)
Spdr Portfolio Short Term Treasury Etf Etf (SPTS)
Freedom 100 Emerging Markets Etf Etf (FRDM)
Ishares 1-5 Year Investment Grade Corporate Bond Etf Etf (IGSB)
Apple (AAPL)
TJX Companies (TJX)
Schwab Us Tips Etf Etf (SCHP)
Microsoft Corporation (MSFT)
Janus Henderson Securitized Income Etf Etf (JSI)
Raytheon Technologies Corp (RTX)
Taiwan Semiconductor Mfg (TSM)

View all positions for 1620 Investment Advisors

Top funds holding Tarsus Pharmaceuticals

BlackRock
Rtw Investments
Deep Track Capital
Paradigm Biocapital Advisors
Jennison Associates
Tang Capital Management
Vanguard Group
Morgan Stanley
Henderson Group
Assenagon Asset Management
Frazier Life Sciences Management
Driehaus Capital Management
Lord, Abbett & Co
Geode Capital Management
Invesco

View all funds holding Tarsus Pharmaceuticals